Abstract:One-hundred and fifty-two of the providers stated that they had heard of EC. The correct timing and dose interval of EC were known by 50% of them. The participants held the belief that EC caused abortion (39.4%), and that it was harmful for the fetus (31.1%). Other prejudices were the possibility of increased unprotected sexual intercourse (78.9%) and a tendency for men to give up condom use (75%); female providers were more prejudiced concerning these statements. The providers' tendency towards the provision … Show more
“…Rather, some respondents worried that use of ECP may discourage regular contraceptive use (17%) or encourage promiscuity (6%). Other studies have found similar concerns among physicians, 7,18,38 although such concerns may be unfounded. 39 It has been shown that compared to clinic access, increased access to ECP via direct pharmacy access or advance provision helps increase ECP use among those in need and allows patients to use it in a more timely manner without changing women's patterns of contraceptive use or sexual risk behaviors.…”
Section: Physicians' Attitudes On Ecp Provision 495mentioning
confidence: 77%
“…7,18,28,[35][36][37][38] Few concerns about the safety and efficacy of taking ECP were raised by physicians. Rather, some respondents worried that use of ECP may discourage regular contraceptive use (17%) or encourage promiscuity (6%).…”
Section: Physicians' Attitudes On Ecp Provision 495mentioning
confidence: 99%
“…31 The reasons for personal opposition to ECP use were not directly queried in our survey, but other studies have shown a correlation between such opposition and the belief that ECP acts as an abortifacient. 7,18,43 However, research shows that ECP does not interfere with an established pregnancy 2 and is unlikely to affect an egg once it has been fertilized even if taken before implantation. 44 These concerns about interference with regular contraceptive use and as a cause of promiscuity and abortion are likely important reasons for some physicians' opposition to the OTC status of ECP as well.…”
Section: Physicians' Attitudes On Ecp Provision 495mentioning
confidence: 99%
“…Most prior research on this issue has focused on a single specialty, such as emergency medicine [18][19][20] or obstetrics/gynecology, 21 even though women routinely access healthcare from physicians in a wide variety of specialties. 22 This study was conceptualized and conducted prior to the recent FDA approval of nonprescription use of Plan B ® and presented a unique opportunity to examine physicians' attitudes and practices about ECP immediately before the change in dispensing method.…”
Objective: Despite the controversy over expanding delivery options for emergency contraceptive pills (ECP), little is known about physicians' attitudes toward over-the-counter (OTC) provision of ECP, and prior research on physicians' practices often has focused on a single specialty. This study examined the attitudes and practices regarding advance provision and OTC status of ECP among physicians in five medical specialties likely to encounter patients in need of ECP.Methods: A mail survey of a random sample of 850 Michigan physicians in family/general medicine, internal medicine, obstetrics/gynecology, pediatrics, and emergency medicine was conducted. Respondents' ECP-related attitudes and practices were assessed, and differences by physician characteristics were examined using chi-square tests and multivariable logistic regression analyses.Results: Two hundred seventy-one physicians responded to the survey (response rate ؍ 32%), with 42% of them favoring OTC provision of ECP and 40% opposing it. Half of respondents never routinely initiated discussions about ECP with their sexually active, female patients, and 77% of respondents did not routinely offer advance prescriptions. After adjusting for other factors, including medical specialty, older physicians (Ն50 years) were significantly more likely than their younger counterparts to support OTC provision of ECP (OR ؍ 2.9, 95% CI 1.7-4.9) or offer advance prescriptions (OR ؍ 2.5, 95% CI 1.1-5.8). Physicians with a specialty in obstetrics/gynecology were 3.5 times (95% CI 1.3-9.8) as likely as physicians in family/general medicine to offer advance prescriptions for ECP, and female physicians were 2.5 (95% CI 1.05-6.0) times as likely as male physicians to offer advance prescriptions. Graduation from a medical school within the United States and practicing in a private practice were marginally associated with a lower likelihood of supporting OTC status of ECP (OR ؍ 0.5, 95% CI: 0.2-1.0; and OR ؍ 0.6, 95% CI 0.3-1.1, respectively).Conclusions: Certain physician characteristics were significantly associated with their ECPrelated attitudes and practices. The majority of physicians surveyed in this study did not offer advance prescriptions for ECP, and few had initiated discussions on ECP with patients, which may pose critical barriers to patients' timely access. 489
“…Rather, some respondents worried that use of ECP may discourage regular contraceptive use (17%) or encourage promiscuity (6%). Other studies have found similar concerns among physicians, 7,18,38 although such concerns may be unfounded. 39 It has been shown that compared to clinic access, increased access to ECP via direct pharmacy access or advance provision helps increase ECP use among those in need and allows patients to use it in a more timely manner without changing women's patterns of contraceptive use or sexual risk behaviors.…”
Section: Physicians' Attitudes On Ecp Provision 495mentioning
confidence: 77%
“…7,18,28,[35][36][37][38] Few concerns about the safety and efficacy of taking ECP were raised by physicians. Rather, some respondents worried that use of ECP may discourage regular contraceptive use (17%) or encourage promiscuity (6%).…”
Section: Physicians' Attitudes On Ecp Provision 495mentioning
confidence: 99%
“…31 The reasons for personal opposition to ECP use were not directly queried in our survey, but other studies have shown a correlation between such opposition and the belief that ECP acts as an abortifacient. 7,18,43 However, research shows that ECP does not interfere with an established pregnancy 2 and is unlikely to affect an egg once it has been fertilized even if taken before implantation. 44 These concerns about interference with regular contraceptive use and as a cause of promiscuity and abortion are likely important reasons for some physicians' opposition to the OTC status of ECP as well.…”
Section: Physicians' Attitudes On Ecp Provision 495mentioning
confidence: 99%
“…Most prior research on this issue has focused on a single specialty, such as emergency medicine [18][19][20] or obstetrics/gynecology, 21 even though women routinely access healthcare from physicians in a wide variety of specialties. 22 This study was conceptualized and conducted prior to the recent FDA approval of nonprescription use of Plan B ® and presented a unique opportunity to examine physicians' attitudes and practices about ECP immediately before the change in dispensing method.…”
Objective: Despite the controversy over expanding delivery options for emergency contraceptive pills (ECP), little is known about physicians' attitudes toward over-the-counter (OTC) provision of ECP, and prior research on physicians' practices often has focused on a single specialty. This study examined the attitudes and practices regarding advance provision and OTC status of ECP among physicians in five medical specialties likely to encounter patients in need of ECP.Methods: A mail survey of a random sample of 850 Michigan physicians in family/general medicine, internal medicine, obstetrics/gynecology, pediatrics, and emergency medicine was conducted. Respondents' ECP-related attitudes and practices were assessed, and differences by physician characteristics were examined using chi-square tests and multivariable logistic regression analyses.Results: Two hundred seventy-one physicians responded to the survey (response rate ؍ 32%), with 42% of them favoring OTC provision of ECP and 40% opposing it. Half of respondents never routinely initiated discussions about ECP with their sexually active, female patients, and 77% of respondents did not routinely offer advance prescriptions. After adjusting for other factors, including medical specialty, older physicians (Ն50 years) were significantly more likely than their younger counterparts to support OTC provision of ECP (OR ؍ 2.9, 95% CI 1.7-4.9) or offer advance prescriptions (OR ؍ 2.5, 95% CI 1.1-5.8). Physicians with a specialty in obstetrics/gynecology were 3.5 times (95% CI 1.3-9.8) as likely as physicians in family/general medicine to offer advance prescriptions for ECP, and female physicians were 2.5 (95% CI 1.05-6.0) times as likely as male physicians to offer advance prescriptions. Graduation from a medical school within the United States and practicing in a private practice were marginally associated with a lower likelihood of supporting OTC status of ECP (OR ؍ 0.5, 95% CI: 0.2-1.0; and OR ؍ 0.6, 95% CI 0.3-1.1, respectively).Conclusions: Certain physician characteristics were significantly associated with their ECPrelated attitudes and practices. The majority of physicians surveyed in this study did not offer advance prescriptions for ECP, and few had initiated discussions on ECP with patients, which may pose critical barriers to patients' timely access. 489
“…Although some women consider a method as "abortive" or "abortifacient" if it has an anti-implantation effect [18,28,35], we preferred to use the term "postfertilization" when referring to this mechanism of action. Moreover, although postimplantation effects are considered as abortion in scientific forums [26,[36][37][38], we also avoided the term "abortifacient" to use less value-laden wordings throughout our study.…”
Objective: Some methods of family planning may occasionally work after fertilization or implantation. These effects may be important to some women. We explored Spanish women's attitudes towards these potential mechanisms of action of family planning methods.Study design: Cross-sectional study in a Spanish representative sample of 848 potentially fertile women, aged 18-49. Data were collected using a 30-item questionnaire about family planning. Logistic regression was used to identify variables associated with women's attitudes towards postfertilization effects.Results: The majority of women were married, held an academic degree and had at least one child. Forty-five percent of women would not consider using a method that may work after fertilization and 57% would not consider using one that may work after implantation. Fortyeight percent of the sample would stop using a method if they learned that it sometimes works after fertilization, increasing to 63% when referring to a method that sometimes works after implantation. Women who believe that human life begins at fertilization, those who believe it is important to distinguish between spontaneous and induced embryo losses and women who report having a religion were less likely to consider the use of a method with some postfertilization effects.
Conclusion:The possibility of postfertilization effects may influence Spanish women's choice of a FP method. Information about mechanisms of action of birth control methods should be disclosed to women so that they can make informed choices.
The objective of this study is to make the public aware of progress, safety, effectiveness of use, acceptance, and over-the-counter availability of emergency contraception (EC). Data were extracted from the literature for the period 2000-2006 via MEDLINE using a keyword, and also from some pre-2000 journals. Randomised trials, reviews, surveys, clinical investigations, and articles relevant to the subject matter are considered in this review. Approximately 85%, 57% and 84% of unintended pregnancy could be prevented by using levonorgestrel, the Yuzpe regimen (levonorgestrel plus ethinylestradiol), and mifepristone, respectively, as EC. Levonorgestrel was more effective than the Yuzpe regimen in preventing pregnancy. A dose of 1.5 mg levonorgestrel seemed to have similar effectiveness as that of split doses (0.75 mg twice) at 12 h apart, and that of a low-dose (10 mg) of mifepristone. Nausea and vomiting, dizzy spells and fatigue were less frequent in women using levonorgestrel only than in those receiving the Yuzpe regimen. The mode of action of EC is associated primarily with inhibition of ovulation. EC acts before implantation and hence does not amount to abortion. Teenagers are more likely to be repeat users of EC. Easy access to EC over the counter is likely to increase its use but will widen the chance of misuse or abuse. Both adolescents and health care providers need to be adequately educated and informed about EC to make this method successful. Over the counter supply of EC without prescription but with pharmacists' counselling may increase reduction of unintended pregnancy and abortion. The controversy surrounding, and opposition to, EC may subside with more awareness and knowledge among the public about its mode of action, safety and effectiveness. Educational programmes on EC and further studies on the psychosocial aspects of its use may resolve hurdles for implementation of 'advance provision' or 'over the counter supply' of EC in the community.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.